BSE · TRANSCHEM.BO
Transchem Limited
₹413.55+₹5.95 (+1.46%)
Transchem Limited’s quoted price sits in the upper half of its reported 52-week range, 4.49% below the high.
Loading market information…
BSE · BIBCL.BO · INR
Stock price, earnings
Quote as of Oct 30, 2026, 07:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Bharat Immunologicals & Biologicals Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 60.06% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bharat Immunologicals & Biologicals Corporation Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bharat Immunologicals & Biologicals Corp. Ltd. operates as a biotechnology enterprise, primarily involved in the development and manufacture of pharmaceutical goods. Its offerings include vital products such as oral polio vaccines, zinc tablets, comprehensive diarrhea management kits, and ready-to-consume therapeutic foods. The firm organizes its operations into several key divisions: Oral Polio Vaccine (OPV), Zinc Tablets, BIB VIT, and BIBSANIT. Founded on March 10, 1989, the company's main office is situated in Bulandshahr, India.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹413.55+₹5.95 (+1.46%)
Transchem Limited’s quoted price sits in the upper half of its reported 52-week range, 4.49% below the high.
₹82.00+₹0.99 (+1.22%)
Jeevan Scientific Technology Limited’s quoted price sits in the upper half of its reported 52-week range, 12.67% below the high.
₹102.50₹0.00 (0.0%)
Raaj Medisafe India Limited’s quoted price sits in the upper half of its reported 52-week range, 7.57% below the high.
₹215.00+₹24.95 (+13.13%)
Makers Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 10.04% below the high.
₹734.00₹0.00 (0.0%)
Mercury Laboratories Limited’s quoted price sits in the lower half of its reported 52-week range, 20.95% below the high.
₹110.00-₹2.90 (-2.57%)
Source Natural Foods & Herbal Supplements Ltd.’s quoted price sits in the lower half of its reported 52-week range, 29.53% below the high.
₹69.00₹0.00 (0.0%)
Sunil Healthcare Ltd.’s quoted price sits in the lower half of its reported 52-week range, 16.17% below the high.
₹63.03-₹2.96 (-4.49%)
Concord Drugs Limited’s quoted price sits in the lower half of its reported 52-week range, 31.87% below the high.
